Guowei Fang
Chief Tech/Sci/R&D Officer at LEGEND BIOTECH CORPORATION
Guowei Fang active positions
Companies | Position | Start | End |
---|---|---|---|
LEGEND BIOTECH CORPORATION | Chief Tech/Sci/R&D Officer | 28/02/2022 | - |
Career history of Guowei Fang
Former positions of Guowei Fang
Companies | Position | Start | End |
---|---|---|---|
PHARMACYCLICS, INC. | Corporate Officer/Principal | - | - |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | - | - |
Training of Guowei Fang
University of Colorado Boulder | Doctorate Degree |
Nanjing University | Undergraduate Degree |
Statistics
International
United States | 3 |
Cayman Islands | 2 |
Canada | 2 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
LEGEND BIOTECH CORPORATION | Health Technology |
Private companies | 2 |
---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
- Stock Market
- Insiders
- Guowei Fang
- Experience